SHILPAMED.NSSHILPAMED.NSNSE
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+4.1%
5Y CAGR+7.4%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+4.1%/yr
vs +11.1%/yr prior
5Y CAGR
+7.4%/yr
Recent deceleration
Acceleration
-7.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$12.86B+11.6%
2024$11.53B+10.5%
2023$10.43B-8.5%
2022$11.40B+26.6%
2021$9.00B+0.1%
2020$8.99B+28.1%
2019$7.01B-6.4%
2018$7.49B+2.6%
2017$7.30B+14.5%
2016$6.38B-